JEMEGZI Trademark

Trademark Overview

On Monday, August 2, 2021, a trademark application was filed for JEMEGZI with the United States Patent and Trademark Office. The USPTO has given the JEMEGZI trademark a serial number of 90860810. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, June 18, 2024. This trademark is owned by Celgene Corporation. The JEMEGZI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for oncology
jemegzi

General Information

Serial Number90860810
Word MarkJEMEGZI
Filing DateMonday, August 2, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, June 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Thursday, January 27, 2022NON-FINAL ACTION WRITTEN
Thursday, August 5, 2021NEW APPLICATION ENTERED
Tuesday, September 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 24, 2022ASSIGNED TO EXAMINER
Thursday, January 27, 2022NON-FINAL ACTION E-MAILED
Thursday, January 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 31, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 31, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 10, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 4, 2023SOU EXTENSION 1 FILED
Wednesday, January 4, 2023SOU EXTENSION 1 GRANTED
Friday, January 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 28, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 28, 2023SOU EXTENSION 2 FILED
Wednesday, June 28, 2023SOU EXTENSION 2 GRANTED
Friday, June 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 2, 2024SOU EXTENSION 3 FILED
Tuesday, January 2, 2024SOU EXTENSION 3 GRANTED
Tuesday, June 18, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 18, 2024SOU EXTENSION 4 GRANTED
Tuesday, June 18, 2024SOU EXTENSION 4 FILED
Thursday, March 27, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 11, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

jemegzi oncology preparations pharmaceutical